Guest guest Posted March 25, 2009 Report Share Posted March 25, 2009 Ann Rheum Dis. 2009 Mar 15. Does anti-MCV has additional value as serological marker in the diagnostic and prognostic work-up of patients with rheumatoid arthritis? A systematic review. Luime JJ, Colin EM, Hazes JM, Lubberts E. Erasmus Medical Centre, Netherlands. OBJECTIVE: To review the diagnostic and prognostic value of anti-MCV in rheumatoid arthritis taken into account the already available serology. METHODS: Medline was searched through Pubmed (1966- May 2008) for anti-MCV and related terms, arthritis and arthropathies. Studies with anti-MCV, arthritis/arthropathy, and primary data on diagnosis and/or prognosis were included. Their methodological quality was assessed using the QUADAS for diagnostic studies and the modified Hayden list for prognostic studies. RESULTS: Of 14 eligible studies, 11 included diagnostic data and 3 included prognostic data. No study evaluated anti-MCV as added diagnostic test to the already available anti-CCP and rheumatoid factor serology. One study included the optimal patient spectrum resulting in sensitivity of 0.59 and specificity of 0.98. Ten diagnostic case-control studies using the same anti-MCV kit showed a sensitivity of 0.64-0.84 and a specificity of 0.79-0.96. This almost equalled the performance of anti-CCP in the same studies. The prognostic evaluation of anti-MCV was limited by differences in study methodology, outcome and statistical modelling. Individual studies showed moderate associations for anti-MCV and radiological progression with the strength of the association comparable to that of anti-CCP. CONCLUSION: Study heterogeneity, choice of study population and methodological limitations limited overall conclusions about the true diagnostic and prognostic test performance of anti-MCV. Evidence from the diagnostic case-control studies suggests that anti-MCV may be used as an alternative for anti-CCP. PMID: 19289382 http://www.ncbi.nlm.nih.gov/pubmed/19289382 Not an MD Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.